HLA-C and neoplasm: Tumor immunotherapy has two signals to regulate T-cell activation, including MHC complexes interacting with T-cell receptors and co-stimulation between T cells and antigen-presenting cells.3, 4To control the balance in the immune system, co-stimulatory and coinhibitory factors, or immune checkpoint proteins, work together.